Form 4: Lexeo Therapeutics' Chief Medical Officer Reports Stock Transactions
SEC Form 4 Filing
Eric Adler, Chief Medical Officer of Lexeo Therapeutics, reports acquisition and disposal of common stock and stock options.
Summary
- Eric Adler, the Chief Medical Officer of Lexeo Therapeutics, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- On January 7, 2025, Adler acquired 43,750 restricted stock units (RSUs) and disposed of 70,625 RSUs.
- He also acquired options to purchase 87,500 shares of common stock at an exercise price of $7.33.
- The RSUs vest over time, with 25% vesting on February 15, 2026, and the remainder vesting quarterly thereafter.
- The stock options also vest over time, with 25% vesting on January 7, 2026, and the remainder vesting monthly thereafter, expiring on January 6, 2035.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral. It reflects standard compensation practices and insider trading reporting.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a key executive.
Key Dates
| Date | Description |
|---|---|
| 01/07/2025 | Date of earliest transaction: acquisition and disposal of RSUs and acquisition of stock options. |
| 01/07/2025 | Stock option grant date. |
| 01/07/2026 | 25% of stock options vest and become exercisable. |
| 01/06/2035 | Expiration date of stock options. |
| 02/15/2026 | 25% of RSUs vest. |
| 01/10/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.